177 related articles for article (PubMed ID: 27725536)
1. Effects of Biologic Agents in Patients with Rheumatoid Arthritis and Amyloidosis Treated with Hemodialysis.
Kuroda T; Tanabe N; Nozawa Y; Sato H; Nakatsue T; Kobayashi D; Wada Y; Saeki T; Nakano M; Narita I
Intern Med; 2016; 55(19):2777-2783. PubMed ID: 27725536
[TBL] [Abstract][Full Text] [Related]
2. Treatment with biologic agents improves the prognosis of patients with rheumatoid arthritis and amyloidosis.
Kuroda T; Tanabe N; Kobayashi D; Sato H; Wada Y; Murakami S; Saeki T; Nakano M; Narita I
J Rheumatol; 2012 Jul; 39(7):1348-54. PubMed ID: 22589255
[TBL] [Abstract][Full Text] [Related]
3. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
4. Treatment persistence among patients with rheumatoid disease (RA, AS, PsA) treated with subcutaneous biologics in Germany.
Lyu R; Govoni M; Ding Q; Black CM; Kachroo S; Fan T; Ogbonnaya A; Donga P; Hill J; Makin C
Rheumatol Int; 2016 Jan; 36(1):143-53. PubMed ID: 26314368
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and drug adherence of biologic monotherapy in routine care of patients with rheumatoid arthritis: a cohort study of patients registered in the Danish biologics registry.
Jørgensen TS; Kristensen LE; Christensen R; Bliddal H; Lorenzen T; Hansen MS; Østergaard M; Jensen J; Zanjani L; Laursen T; Butt S; Dam MY; Lindegaard HM; Espesen J; Hendricks O; Kumar P; Kincses A; Larsen LH; Andersen M; Næser EK; Jensen DV; Grydehøj J; Unger B; Dufour N; Sørensen V; Vildhøj S; Hansen IM; Raun J; Krogh NS; Hetland ML
Rheumatology (Oxford); 2015 Dec; 54(12):2156-65. PubMed ID: 26175471
[TBL] [Abstract][Full Text] [Related]
6. Programmed initiation of hemodialysis for systemic amyloidosis patients associated with rheumatoid arthritis.
Kuroda T; Tanabe N; Kobayashi D; Sato H; Wada Y; Murakami S; Sakatsume M; Nakano M; Narita I
Rheumatol Int; 2011 Sep; 31(9):1177-82. PubMed ID: 20349236
[TBL] [Abstract][Full Text] [Related]
7. Real-world Effectiveness of Biologic Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis After Etanercept Discontinuation in the United Kingdom, France, and Germany.
Li N; Betts KA; Messali AJ; Skup M; Garg V
Clin Ther; 2017 Aug; 39(8):1618-1627. PubMed ID: 28729087
[TBL] [Abstract][Full Text] [Related]
8. A European chart review study on early rheumatoid arthritis treatment patterns, clinical outcomes, and healthcare utilization.
Emery P; Solem C; Majer I; Cappelleri JC; Tarallo M
Rheumatol Int; 2015 Nov; 35(11):1837-49. PubMed ID: 26164150
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of etanercept in patients with AA amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Baba S
Clin Exp Rheumatol; 2007; 25(4):518-22. PubMed ID: 17888205
[TBL] [Abstract][Full Text] [Related]
10. A multicenter report of biologic agents for the treatment of secondary amyloidosis in Turkish rheumatoid arthritis and ankylosing spondylitis patients.
Pamuk ÖN; Kalyoncu U; Aksu K; Omma A; Pehlivan Y; Çağatay Y; Küçükşahin O; Dönmez S; Çetin GY; Mercan R; Bayındır Ö; Çefle A; Yıldız F; Balkarlı A; Kılıç L; Çakır N; Kısacık B; Öksüz MF; Çobankara V; Onat AM; Sayarlıoğlu M; Öztürk MA; Pamuk GE; Akkoç N
Rheumatol Int; 2016 Jul; 36(7):945-53. PubMed ID: 27221456
[TBL] [Abstract][Full Text] [Related]
11. Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis.
Miyagawa I; Nakayamada S; Saito K; Hanami K; Nawata M; Sawamukai N; Nakano K; Yamaoka K; Tanaka Y
Mod Rheumatol; 2014 May; 24(3):405-9. PubMed ID: 24252016
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of biologics on cardiovascular risk among older patients with rheumatoid arthritis.
Zhang J; Xie F; Yun H; Chen L; Muntner P; Levitan EB; Safford MM; Kent ST; Osterman MT; Lewis JD; Saag K; Singh JA; Curtis JR
Ann Rheum Dis; 2016 Oct; 75(10):1813-8. PubMed ID: 26792814
[TBL] [Abstract][Full Text] [Related]
13. Economic Burden and Treatment Patterns of Cycling between Conventional Synthetic Disease-modifying Antirheumatic Drugs Among Biologic-treated Patients with Rheumatoid Arthritis.
Betts KA; Griffith J; Ganguli A; Li N; Douglas K; Wu EQ
Clin Ther; 2016 May; 38(5):1205-16. PubMed ID: 27045991
[TBL] [Abstract][Full Text] [Related]
14. Long-term mortality outcome in patients with reactive amyloidosis associated with rheumatoid arthritis.
Kuroda T; Tanabe N; Harada T; Murakami S; Hasegawa H; Sakatsume M; Nakano M; Gejyo F
Clin Rheumatol; 2006 Jul; 25(4):498-505. PubMed ID: 16267602
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with reactive amyloidosis associated with rheumatoid arthritis in dialysis treatment.
Kuroda T; Tanabe N; Sato H; Ajiro J; Wada Y; Murakami S; Hasegawa H; Sakatsume M; Nakano M; Gejyo F
Rheumatol Int; 2006 Oct; 26(12):1147-53. PubMed ID: 16953393
[TBL] [Abstract][Full Text] [Related]
16. Drug adherence, response and predictors thereof for tocilizumab in patients with rheumatoid arthritis: results from the Swedish biologics register.
Forsblad-d'Elia H; Bengtsson K; Kristensen LE; Jacobsson LT
Rheumatology (Oxford); 2015 Jul; 54(7):1186-93. PubMed ID: 25505001
[TBL] [Abstract][Full Text] [Related]
17. Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis.
Kawashima H; Kagami SI; Kashiwakuma D; Takahashi K; Yokota M; Furuta S; Iwamoto I
Rheumatol Int; 2017 Mar; 37(3):369-376. PubMed ID: 27999943
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
Nakamura T; Higashi S; Tomoda K; Tsukano M; Shono M
Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
[TBL] [Abstract][Full Text] [Related]
19. Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis.
Hattori Y; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Hoshino J; Sawa N; Oohashi K; Takaichi K
Amyloid; 2012 Mar; 19(1):37-40. PubMed ID: 22260742
[TBL] [Abstract][Full Text] [Related]
20. Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare.
Yun H; Xie F; Delzell E; Levitan EB; Chen L; Lewis JD; Saag KG; Beukelman T; Winthrop KL; Baddley JW; Curtis JR
Arthritis Rheumatol; 2016 Jan; 68(1):56-66. PubMed ID: 26315675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
